A. Hoofnagle and J. Heinecke, Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins, The Journal of Lipid Research, vol.50, issue.10, pp.1967-1975, 2009.
DOI : 10.1194/jlr.R900015-JLR200

P. Davidsson, J. Hulthe, B. Fagerberg, and G. Camejo, Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.156-163, 2010.
DOI : 10.1161/ATVBAHA.108.179317

M. Oresic, V. Hanninen, and A. Vidal-puig, Lipidomics: a new window to biomedical frontiers, Trends in Biotechnology, vol.26, issue.12, pp.647-652, 2008.
DOI : 10.1016/j.tibtech.2008.09.001

T. Seppanen-laakso and M. Oresic, How to study lipidomes, Journal of Molecular Endocrinology, vol.42, issue.3, pp.185-190, 2009.
DOI : 10.1677/JME-08-0150

@. Wiesner, P. Leidl, K. Boettcher, and A. , Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry, This is a pioneering study of the lipidomics of isolated plasma lipoproteins (VLDL, LDL, HDL), pp.574-585, 2009.
DOI : 10.1194/jlr.D800028-JLR200

M. Sysi-aho, A. Vehtari, and V. Velagapudi, Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles, Bioinformatics, vol.23, issue.13, pp.519-528, 2007.
DOI : 10.1093/bioinformatics/btm181

@. Kontush, A. Therond, P. Zerrad, and A. , Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities, This is a pioneering study of the lipidome of isolated lipoprotein subclasses, pp.1843-1849, 2007.
DOI : 10.1161/ATVBAHA.107.145672
URL : https://hal.archives-ouvertes.fr/inserm-00409657

B. Hansel, P. Giral, and E. Nobecourt, Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.10, pp.4963-4971, 2004.
DOI : 10.1210/jc.2004-0305

A. Kontush, S. Chantepie, and M. Chapman, Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.10, pp.1881-1888, 2003.
DOI : 10.1161/01.ATV.0000091338.93223.E8

A. Nilsson and R. Duan, Absorption and lipoprotein transport of sphingomyelin, The Journal of Lipid Research, vol.47, issue.1, pp.154-171, 2006.
DOI : 10.1194/jlr.M500357-JLR200

P. Duong, H. Collins, and M. Nickel, Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I, The Journal of Lipid Research, vol.47, issue.4, pp.832-843, 2006.
DOI : 10.1194/jlr.M500531-JLR200

P. Subbaiah and M. Liu, Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction, J Biol Chem, vol.268, pp.20156-20163, 1993.

B. Asztalos, W. Zhang, P. Roheim, and L. Wong, Role of Free Apolipoprotein A-I in Cholesterol Efflux : Formation of Pre????-Migrating High-Density Lipoprotein Particles, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.9, pp.1630-1636, 1997.
DOI : 10.1161/01.ATV.17.9.1630

J. De-souza, C. Vindis, and A. Negre-salvayre, Small, dense HDL3 particles attenuates apoptosis in endothelial cells: Pivotal role of apolipoprotein A-I, Journal of Cellular and Molecular Medicine, 2009.
DOI : 10.1111/j.1582-4934.2009.00713.x
URL : https://hal.archives-ouvertes.fr/inserm-00410382

G. Catalano, J. Z. Frisdal, and E. , Torcetrapib Differentially Modulates the Biological Activities of HDL2 and HDL3 Particles in the Reverse Cholesterol Transport Pathway, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.2, pp.268-275, 2009.
DOI : 10.1161/ATVBAHA.108.179416

A. Zerrad-saadi, P. Therond, and S. Chantepie, HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.12, pp.2169-2175, 2009.
DOI : 10.1161/ATVBAHA.109.194555

A. Taylor, T. Villines, and E. Stanek, Extended-Release Niacin or Ezetimibe and Carotid Intima???Media Thickness, New England Journal of Medicine, vol.361, issue.22, pp.2113-2122, 2009.
DOI : 10.1056/NEJMoa0907569

A. Kontush, M. Guerin, and M. Chapman, Spotlight on HDL-raising therapies: insights from the torcetrapib trials, Nature Clinical Practice Cardiovascular Medicine, vol.34, issue.6, pp.329-336, 2008.
DOI : 10.1038/ncpcardio1191

@. Pietilainen, K. Sysi-aho, M. Rissanen, and A. , Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects ??? A Monozygotic Twin Study, PLoS ONE, vol.10, issue.2, p.218, 2007.
DOI : 10.1371/journal.pone.0000218.s001

V. De-mello, M. Lankinen, and U. Schwab, Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease, Diabetologia, vol.54, issue.12, pp.2612-2615, 2009.
DOI : 10.1007/s00125-009-1482-9

A. Kotronen, T. Seppanen-laakso, and J. Westerbacka, Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra-abdominal Adipose Tissue, and Serum, Obesity, vol.8, issue.5, 2009.
DOI : 10.1038/sj.ejcn.1600744

A. @bullet-kotronen, V. Velagapudi, and L. Yetukuri, Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations, Diabetologia, vol.5, issue.4, pp.684-690, 2009.
DOI : 10.1007/s00125-009-1282-2

P. Puri, M. Wiest, and O. Cheung, The plasma lipidomic signature of nonalcoholic steatohepatitis, Hepatology, vol.39, issue.6, pp.1827-1838, 2009.
DOI : 10.1002/hep.23229

A. Kotronen, T. Seppanen-laakso, and J. Westerbacka, Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver, Diabetes, vol.58, issue.1, pp.203-208, 2009.
DOI : 10.2337/db08-1074

M. Kolak, J. Westerbacka, and V. Velagapudi, Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity, Diabetes, vol.56, issue.8, pp.1960-1968, 2007.
DOI : 10.2337/db07-0111

L. Yetukuri, M. Katajamaa, and G. Medina-gomez, Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis, BMC Systems Biology, vol.1, issue.1, p.12, 2007.
DOI : 10.1186/1752-0509-1-12

@. Graessler, J. Schwudke, D. Schwarz, and P. , Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients:e6261. This is the first demonstration of abnormalities in the plasma lipidome in hypertension, PLoS One, vol.4, 2009.

@. Guerrera, I. Astarita, G. Jais, and J. , A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients, PLoS ONE, vol.41, issue.2, 2009.
DOI : 10.1371/journal.pone.0007735.t003

U. Schwab, T. Seppanen-laakso, and L. Yetukuri, Triacylglycerol Fatty Acid Composition in Diet-Induced Weight Loss in Subjects with Abnormal Glucose Metabolism ??? the GENOBIN Study, PLoS ONE, vol.72, issue.7, p.2630, 2008.
DOI : 10.1371/journal.pone.0002630.s002

M. Lankinen, U. Schwab, and A. Erkkila, Fatty Fish Intake Decreases Lipids Related to Inflammation and Insulin Signaling???A Lipidomics Approach, PLoS ONE, vol.1, issue.4, p.5258, 2009.
DOI : 10.1371/journal.pone.0005258.s002

M. Lankinen, U. Schwab, and P. Gopalacharyulu, Dietary carbohydrate modification alters serum metabolic profiles in individuals with the metabolic syndrome, Nutrition, Metabolism and Cardiovascular Diseases, vol.20, issue.4, 2009.
DOI : 10.1016/j.numecd.2009.04.009

R. Kekkonen, M. Sysi-aho, and T. Seppanen-laakso, Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults, World Journal of Gastroenterology, vol.14, issue.20, pp.3188-3194, 2008.
DOI : 10.3748/wjg.14.3188

E. Altmaier, G. Kastenmuller, and W. Romisch-margl, Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics, Molecular Nutrition & Food Research, vol.163, issue.11, pp.1357-1365, 2009.
DOI : 10.1002/mnfr.200900116

@. Bergheanu, S. Reijmers, T. Zwinderman, and A. , Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins, This is a pioneering study of the differential effects of rosuvastatin and atorvastatin on the plasma lipidome, notably on the SM/(SM+PC) ratio, pp.2477-2487, 2008.
DOI : 10.1185/03007990802321709

X. Jiang, F. Paultre, and T. Pearson, Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.12, pp.2614-2618, 2000.
DOI : 10.1161/01.ATV.20.12.2614

R. Laaksonen, M. Katajamaa, and H. Paiva, A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle, PLoS ONE, vol.100, issue.1, p.97, 2006.
DOI : 10.1371/journal.pone.0000097.s041

R. Laaksonen, M. Janis, and M. Oresic, Lipidomics-Based Safety Biomarkers for Lipid-Lowering Treatments, Angiology, vol.78, issue.1, 2008.
DOI : 10.1177/0003319708321106
URL : http://dx.doi.org/10.1177/0003319708321106

S. Tselmin, G. Schmitz, and U. Julius, Acute effects of lipid apheresis on human serum lipidome, Atherosclerosis Supplements, vol.10, issue.5, p.27, 2009.
DOI : 10.1016/S1567-5688(09)71806-9